Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study.

McMahon BA, Galligan M, Redahan L, Martin T, Meaney E, Cotter EJ, Murphy N, Hannon C, Doran P, Marsh B, Nichol A, Murray PT.

Am J Nephrol. 2019 Jun 14:1-10. doi: 10.1159/000500231. [Epub ahead of print]

PMID:
31203271
2.

Utility of Urine Neutrophil Gelatinase-Associated Lipocalin for Worsening Renal Function during Hospitalization for Acute Heart Failure: Primary findings for urine N-gal Acute Kidney Injury N-gal Evaluation of Symptomatic heart faIlure Study (AKINESIS).

Murray PT, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müeller GA, Birkhahn R, Horiuchi Y, Clopton P, Taub P, Vilke GM, Barnett O, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Maisel A.

J Card Fail. 2019 May 22. pii: S1071-9164(19)30071-5. doi: 10.1016/j.cardfail.2019.05.009. [Epub ahead of print]

PMID:
31128242
3.

A Novel Fluorescent Clinical Method to Rapidly Quantify Plasma Volume.

Molitoris BA, George AG, Murray PT, Meier D, Reilly ES, Barreto E, Sandoval RM, Rizk DV, Shaw AD, Peacock WF.

Cardiorenal Med. 2019;9(3):168-179. doi: 10.1159/000496480. Epub 2019 Mar 7.

4.

Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.

Pickkers P, Mehta RL, Murray PT, Joannidis M, Molitoris BA, Kellum JA, Bachler M, Hoste EAJ, Hoiting O, Krell K, Ostermann M, Rozendaal W, Valkonen M, Brealey D, Beishuizen A, Meziani F, Murugan R, de Geus H, Payen D, van den Berg E, Arend J; STOP-AKI Investigators.

JAMA. 2018 Nov 20;320(19):1998-2009. doi: 10.1001/jama.2018.14283.

5.

Erratum.

Stack AG, Li X, Kaballo MA, Elsayed ME, Johnson H, Murray PT, Saran R, Browne LD.

Nephrol Dial Transplant. 2018 Sep 11. doi: 10.1093/ndt/gfy288. [Epub ahead of print] No abstract available.

PMID:
30215812
6.

Cytokine Clearances in Critically Ill Patients on Continuous Renal Replacement Therapy.

Chen LX, Demirjian S, Udani SM, Trevino SA, Murray PT, Koyner JL.

Blood Purif. 2018;46(4):315-322. doi: 10.1159/000492025. Epub 2018 Aug 14.

PMID:
30107381
7.

Temporal trends in acute kidney injury across health care settings in the Irish health system: a cohort study.

Stack AG, Li X, Kaballo M, Elsayed ME, Johnson H, Murray PT, Saran R, Browne LD.

Nephrol Dial Transplant. 2018 Aug 7. doi: 10.1093/ndt/gfy226. [Epub ahead of print]

PMID:
30099517
8.

Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C.

Jelinek MJ, Lee SM, Wyche Okpareke A, Wing C, Koyner JL, Murray PT, Stadler WM, O' Donnell PH.

Clin Transl Sci. 2018 Jul;11(4):420-427. doi: 10.1111/cts.12547. Epub 2018 Apr 24.

9.

Novel Biomarkers of Drug-Induced Kidney Injury.

Redahan L, Murray PT.

Clin Pharmacol Ther. 2018 Mar;103(3):396-398. doi: 10.1002/cpt.999. Review.

PMID:
29417562
10.

Drug management in acute kidney disease - Report of the Acute Disease Quality Initiative XVI meeting.

Ostermann M, Chawla LS, Forni LG, Kane-Gill SL, Kellum JA, Koyner J, Murray PT, Ronco C, Goldstein SL; ADQI 16 workgroup.

Br J Clin Pharmacol. 2018 Feb;84(2):396-403. doi: 10.1111/bcp.13449. Epub 2017 Dec 1.

11.

Biomarkers of drug-induced kidney injury.

Redahan L, Murray PT.

Curr Opin Crit Care. 2017 Dec;23(6):463-469. doi: 10.1097/MCC.0000000000000464. Review.

PMID:
29023315
12.

Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).

Peters E, Mehta RL, Murray PT, Hummel J, Joannidis M, Kellum JA, Arend J, Pickkers P.

BMJ Open. 2016 Sep 27;6(9):e012371. doi: 10.1136/bmjopen-2016-012371.

13.

Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study.

Maisel AS, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müller GA, Birkhahn R, Clopton P, Taub P, Vilke GM, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Murray PT.

J Am Coll Cardiol. 2016 Sep 27;68(13):1420-1431. doi: 10.1016/j.jacc.2016.06.055.

14.

Rationale and Design of the Genetic Contribution to Drug Induced Renal Injury (DIRECT) Study.

Awdishu L, Nievergelt CM, Davenport A, Murray PT, Macedo E, Cerda J, Chakaravarthi R, Ramachandra Rao SP, Holden A, Goldstein SL, Mehta RL.

Kidney Int Rep. 2016 Aug 24;1(4):288-298. doi: 10.1016/j.ekir.2016.08.010. eCollection 2016 Nov.

15.

Urinary Soluble CD163 in Active Renal Vasculitis.

O'Reilly VP, Wong L, Kennedy C, Elliot LA, O'Meachair S, Coughlan AM, O'Brien EC, Ryan MM, Sandoval D, Connolly E, Dekkema GJ, Lau J, Abdulahad WH, Sanders JS, Heeringa P, Buckley C, O'Brien C, Finn S, Cohen CD, Lindemeyer MT, Hickey FB, O'Hara PV, Feighery C, Moran SM, Mellotte G, Clarkson MR, Dorman AJ, Murray PT, Little MA.

J Am Soc Nephrol. 2016 Sep;27(9):2906-16. doi: 10.1681/ASN.2015050511. Epub 2016 Mar 3. Erratum in: J Am Soc Nephrol. 2018 Aug;29(8):2255.

16.

Associations of Perfusate Biomarkers and Pump Parameters With Delayed Graft Function and Deceased Donor Kidney Allograft Function.

Parikh CR, Hall IE, Bhangoo RS, Ficek J, Abt PL, Thiessen-Philbrook H, Lin H, Bimali M, Murray PT, Rao V, Schröppel B, Doshi MD, Weng FL, Reese PP.

Am J Transplant. 2016 May;16(5):1526-39. doi: 10.1111/ajt.13655. Epub 2016 Feb 17.

17.

Drug therapies to delay the progression of chronic kidney disease.

Ward F, Holian J, Murray PT.

Clin Med (Lond). 2015 Dec;15(6):550-7. doi: 10.7861/clinmedicine.15-6-550. Review.

18.

Phenotype standardization for drug-induced kidney disease.

Mehta RL, Awdishu L, Davenport A, Murray PT, Macedo E, Cerda J, Chakaravarthi R, Holden AL, Goldstein SL.

Kidney Int. 2015 Aug;88(2):226-34. doi: 10.1038/ki.2015.115. Epub 2015 Apr 8.

19.

Morphology dependent field emission of acid-spun carbon nanotube fibers.

Fairchild SB, Boeckl J, Back TC, Ferguson JB, Koerner H, Murray PT, Maruyama B, Lange MA, Cahay MM, Behabtu N, Young CC, Pasquali M, Lockwood NP, Averett KL, Gruen G, Tsentalovich DE.

Nanotechnology. 2015 Mar 13;26(10):105706. doi: 10.1088/0957-4484/26/10/105706. Epub 2015 Feb 19.

PMID:
25694166
20.

Choice of fluid in acute illness: what should be given? An international consensus.

Raghunathan K, Murray PT, Beattie WS, Lobo DN, Myburgh J, Sladen R, Kellum JA, Mythen MG, Shaw AD; ADQI XII Investigators Group.

Br J Anaesth. 2014 Nov;113(5):772-83. doi: 10.1093/bja/aeu301. Review. Erratum in: Br J Anaesth. 2015 Jan;114(1):175.

21.

Detection of high-sensitivity troponin in outpatients with stable pulmonary hypertension identifies a subgroup at higher risk of adverse outcomes.

Roy AK, McCullagh BN, Segurado R, McGorrian C, Keane E, Keaney J, Fitzgibbon MN, Mahon NG, Murray PT, Gaine SP.

J Card Fail. 2014 Jan;20(1):31-7. doi: 10.1016/j.cardfail.2013.12.001. Epub 2013 Dec 12.

PMID:
24333348
22.

Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.

Murray PT, Mehta RL, Shaw A, Ronco C, Endre Z, Kellum JA, Chawla LS, Cruz D, Ince C, Okusa MD; ADQI 10 workgroup.

Kidney Int. 2014 Mar;85(3):513-21. doi: 10.1038/ki.2013.374. Epub 2013 Oct 9.

23.

Pulsed-laser deposited transition-metal carbides for field-emission cathode coatings.

Back T, Fairchild SB, Averett K, Maruyama B, Pierce N, Cahay M, Murray PT.

ACS Appl Mater Interfaces. 2013 Sep 25;5(18):9241-6. doi: 10.1021/am403362w. Epub 2013 Sep 16.

PMID:
23988076
24.

A Comparison of Traditional and Novel Definitions (RIFLE, AKIN, and KDIGO) of Acute Kidney Injury for the Prediction of Outcomes in Acute Decompensated Heart Failure.

Roy AK, Mc Gorrian C, Treacy C, Kavanaugh E, Brennan A, Mahon NG, Murray PT.

Cardiorenal Med. 2013 Apr;3(1):26-37. doi: 10.1159/000347037. Epub 2013 Feb 26.

25.

Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

Haase M, Müller C, Damman K, Murray PT, Kellum JA, Ronco C, McCullough PA.

Contrib Nephrol. 2013;182:99-116. doi: 10.1159/000349969. Epub 2013 May 13.

26.

Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

McCullough PA, Kellum JA, Haase M, Müller C, Damman K, Murray PT, Cruz D, House AA, Schmidt-Ott KM, Vescovo G, Bagshaw SM, Hoste EA, Briguori C, Braam B, Chawla LS, Costanzo MR, Tumlin JA, Herzog CA, Mehta RL, Rabb H, Shaw AD, Singbartl K, Ronco C.

Contrib Nephrol. 2013;182:82-98. doi: 10.1159/000349966. Epub 2013 May 13.

PMID:
23689657
27.

Physiological biomarkers of acute kidney injury: a conceptual approach to improving outcomes.

Okusa MD, Jaber BL, Doran P, Duranteau J, Yang L, Murray PT, Mehta RL, Ince C.

Contrib Nephrol. 2013;182:65-81. doi: 10.1159/000349967. Epub 2013 May 13.

28.

Use of biomarkers to assess prognosis and guide management of patients with acute kidney injury.

Cruz DN, Bagshaw SM, Maisel A, Lewington A, Thadhani R, Chakravarthi R, Murray PT, Mehta RL, Chawla LS.

Contrib Nephrol. 2013;182:45-64. doi: 10.1159/000349965. Epub 2013 May 13.

PMID:
23689655
29.

Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference.

Endre ZH, Kellum JA, Di Somma S, Doi K, Goldstein SL, Koyner JL, Macedo E, Mehta RL, Murray PT.

Contrib Nephrol. 2013;182:30-44. doi: 10.1159/000349964. Epub 2013 May 13.

PMID:
23689654
30.

Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference.

McCullough PA, Shaw AD, Haase M, Bouchard J, Waikar SS, Siew ED, Murray PT, Mehta RL, Ronco C.

Contrib Nephrol. 2013;182:13-29. doi: 10.1159/000349963. Epub 2013 May 13.

PMID:
23689653
31.

Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI).

McCullough PA, Bouchard J, Waikar SS, Siew ED, Endre ZH, Goldstein SL, Koyner JL, Macedo E, Doi K, Di Somma S, Lewington A, Thadhani R, Chakravarthi R, Ice C, Okusa MD, Duranteau J, Doran P, Yang L, Jaber BL, Meehan S, Kellum JA, Haase M, Murray PT, Cruz D, Maisel A, Bagshaw SM, Chawla LS, Mehta RL, Shaw AD, Ronco C.

Contrib Nephrol. 2013;182:5-12. doi: 10.1159/000349962. Epub 2013 May 13.

32.

Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial.

Haase M, Haase-Fielitz A, Plass M, Kuppe H, Hetzer R, Hannon C, Murray PT, Bailey MJ, Bellomo R, Bagshaw SM.

PLoS Med. 2013;10(4):e1001426. doi: 10.1371/journal.pmed.1001426. Epub 2013 Apr 16.

33.

Contrast-induced acute kidney injury: how much contrast is safe?

Keaney JJ, Hannon CM, Murray PT.

Nephrol Dial Transplant. 2013 Jun;28(6):1376-83. doi: 10.1093/ndt/gfs602. Epub 2013 Feb 14. Review.

PMID:
23413087
34.

Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials.

Okusa MD, Molitoris BA, Palevsky PM, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Faubel S, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2012 May;7(5):851-5. doi: 10.2215/CJN.12811211. Epub 2012 Mar 22.

35.

Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings.

Molitoris BA, Okusa MD, Palevsky PM, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Faubel SG, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2012 May;7(5):856-60. doi: 10.2215/CJN.12821211. Epub 2012 Mar 22.

36.

Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology.

Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2012 May;7(5):844-50. doi: 10.2215/CJN.12791211. Epub 2012 Mar 22.

37.

Establishment of a reference interval for urinary neutrophil gelatinase-associated lipocalin.

Cullen MR, Murray PT, Fitzgibbon MC.

Ann Clin Biochem. 2012 Mar;49(Pt 2):190-3. doi: 10.1258/acb.2011.011105. Epub 2012 Feb 9.

PMID:
22323662
38.
39.

Acute kidney injury biomarkers and endpoints for clinical trials.

Murray PT.

Contrib Nephrol. 2011;171:208-12. doi: 10.1159/000327326. Epub 2011 May 23. Review.

PMID:
21625113
40.

Urinary glutathione S-transferases in the pathogenesis and diagnostic evaluation of acute kidney injury following cardiac surgery: a critical review.

McMahon BA, Koyner JL, Murray PT.

Curr Opin Crit Care. 2010 Dec;16(6):550-5. doi: 10.1097/MCC.0b013e32833fdd9a. Review.

41.

Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury.

Koyner JL, Vaidya VS, Bennett MR, Ma Q, Worcester E, Akhter SA, Raman J, Jeevanandam V, O'Connor MF, Devarajan P, Bonventre JV, Murray PT.

Clin J Am Soc Nephrol. 2010 Dec;5(12):2154-65. doi: 10.2215/CJN.00740110. Epub 2010 Aug 26.

42.

Urinary collagen IV and πGST: potential biomarkers for detecting localized kidney injury in diabetes--a pilot study.

Cawood TJ, Bashir M, Brady J, Murray B, Murray PT, O'Shea D.

Am J Nephrol. 2010;32(3):219-25. doi: 10.1159/000317531. Epub 2010 Jul 20.

PMID:
20664197
43.

The kidney in respiratory failure and mechanical ventilation.

Murray PT.

Contrib Nephrol. 2010;165:159-65. doi: 10.1159/000313755. Epub 2010 Apr 20.

PMID:
20427966
44.

Urinary liver fatty acid-binding protein: another novel biomarker of acute kidney injury.

McMahon BA, Murray PT.

Kidney Int. 2010 Apr;77(8):657-9. doi: 10.1038/ki.2010.5. Review.

45.

Mechanical ventilation and the kidney.

Koyner JL, Murray PT.

Blood Purif. 2010;29(1):52-68. doi: 10.1159/000259585. Epub 2009 Nov 19. Review.

46.

The use of renal replacement therapy in acute decompensated heart failure.

Udani SM, Murray PT.

Semin Dial. 2009 Mar-Apr;22(2):173-9. doi: 10.1111/j.1525-139X.2008.00542.x. Review.

PMID:
19426424
47.

"Drug dosing in the intensive care unit: the critically ill are a special population too".

Murray PT.

Crit Care Med. 2009 Jan;37(1):342-3. doi: 10.1097/CCM.0b013e318193522d. No abstract available.

PMID:
19112294
48.

Role of water in super growth of single-walled carbon nanotube carpets.

Amama PB, Pint CL, McJilton L, Kim SM, Stach EA, Murray PT, Hauge RH, Maruyama B.

Nano Lett. 2009 Jan;9(1):44-9. doi: 10.1021/nl801876h.

PMID:
19046079
49.

Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury?

Koyner JL, Sher Ali R, Murray PT.

Nephron Exp Nephrol. 2008;109(4):e109-17. doi: 10.1159/000142935. Epub 2008 Sep 18. Review.

PMID:
18802373
50.

Association of prealbumin level with mortality in patients with acute kidney injury.

Murray PT.

Nat Clin Pract Nephrol. 2008 Oct;4(10):528-9. doi: 10.1038/ncpneph0930. Epub 2008 Aug 26.

PMID:
18725913

Supplemental Content

Loading ...
Support Center